LLY

1,160.14

+2.66%↑

JNJ

231.99

-0.28%↓

ABBV

222.4

-2.17%↓

UNH

404.23

+0.98%↑

MRK

119.9

-0.85%↓

LLY

1,160.14

+2.66%↑

JNJ

231.99

-0.28%↓

ABBV

222.4

-2.17%↓

UNH

404.23

+0.98%↑

MRK

119.9

-0.85%↓

LLY

1,160.14

+2.66%↑

JNJ

231.99

-0.28%↓

ABBV

222.4

-2.17%↓

UNH

404.23

+0.98%↑

MRK

119.9

-0.85%↓

LLY

1,160.14

+2.66%↑

JNJ

231.99

-0.28%↓

ABBV

222.4

-2.17%↓

UNH

404.23

+0.98%↑

MRK

119.9

-0.85%↓

LLY

1,160.14

+2.66%↑

JNJ

231.99

-0.28%↓

ABBV

222.4

-2.17%↓

UNH

404.23

+0.98%↑

MRK

119.9

-0.85%↓

Home・Akciju saraksts・Quanterix Corp

Quanterix Corp

Atvērts

SektorsVeselības aprūpe

3.18 -3.05

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.18

Max

3.34

Galvenie mērījumi
By Trading Economics
Ienākumi	5.6M -18M
Pārdošana	-7.4M 36M
EPS	0.16
Peļņas marža	-48.17
Darbinieki	450
EBITDA	1.5M -15M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+21.21% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 6. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	6.3M 165M
Iepriekšējā atvēršanas cena	6.23
Iepriekšējā slēgšanas cena	3.18

Ziņu noskaņojums

By Acuity

50%

139 / 344 Rangs Healthcare

Quanterix Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 5. jūn. 19:20 UTC

Galvenie tirgus virzītāji

Meta Platforms Slips on Report of Plans for Multibillion-Dollar Offering to Fund AI Buildout

2026. g. 7. jūn. 23:46 UTC

Tirgus saruna

Nikkei Likely to Fall After U.S. Tech Selloff -- Market Talk

2026. g. 7. jūn. 23:36 UTC

Tirgus saruna

Oil Prices Rise Amid Escalating Supply Disruption Concerns -- Market Talk

2026. g. 7. jūn. 18:00 UTC

Peļņas

Inflation Readings, Oracle Earnings, the SpaceX IPO, and More to Watch This Week -- Barrons.com

2026. g. 6. jūn. 12:40 UTC

Iegādes, apvienošanās, pārņemšana

Correction to Texas Billionaires Article America's Resort -- WSJ

2026. g. 6. jūn. 08:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 6. jūn. 08:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 6. jūn. 04:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 6. jūn. 00:14 UTC

Iegādes, apvienošanās, pārņemšana

4 Arm Execs Sold $26 Million in Stock, but They Missed a High -- Barrons.com

2026. g. 5. jūn. 21:27 UTC

Peļņas

Carnage in Chip Stocks Hits Extra Hard in Top-Heavy Market -- WSJ

2026. g. 5. jūn. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 5. jūn. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 5. jūn. 20:20 UTC

Iegādes, apvienošanās, pārņemšana

Altice France Group Had Granted Initial Exclusivity Period to Consortium Until May 15, Which Was Then Extended to June 5

2026. g. 5. jūn. 20:19 UTC

Iegādes, apvienošanās, pārņemšana

Altice France Group, Bouygues Telecom, Free-iliad Group, Orange Exclusivity Period Extended by 48 Hours

2026. g. 5. jūn. 20:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 5. jūn. 19:26 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 5. jūn. 19:26 UTC

Tirgus saruna

Hog Futures Tumble to Close Week -- Market Talk

2026. g. 5. jūn. 19:10 UTC

Tirgus saruna

Canada's GDP Targets From AI-Related Spending Require Second Look -- Market Talk

2026. g. 5. jūn. 19:03 UTC

Tirgus saruna

Oil Falls As Market Holds Out Hope for End to Conflict -- Market Talk

2026. g. 5. jūn. 18:59 UTC

Tirgus saruna

U.S. Natural-Gas Futures Pull Back After Gains -- Market Talk

2026. g. 5. jūn. 18:47 UTC

Tirgus saruna

Canada's Labor Market 'Retains Some Weakness' Despite Stellar May Report -- Market Talk

2026. g. 5. jūn. 18:34 UTC

Tirgus saruna

Hyperliquid ETFs Have Inflows Despite Crypto Weakness -- Market Talk

2026. g. 5. jūn. 18:33 UTC

Iegādes, apvienošanās, pārņemšana

The U.S. Government Could Take a Stake in OpenAI. What That Means for Tech Stocks. -- Barrons.com

2026. g. 5. jūn. 17:50 UTC

Peļņas

Lululemon Slumps on Earnings. Bargain Hunters Beware. -- Barrons.com

2026. g. 5. jūn. 17:27 UTC

Tirgus saruna

U.S. Oil Rig Count Rises for 6th Straight Week -- Market Talk

2026. g. 5. jūn. 16:48 UTC

Iegādes, apvienošanās, pārņemšana

Ryan Cohen Is Ready to Talk About eBay. For Real. -- Barrons.com

2026. g. 5. jūn. 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 5. jūn. 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 5. jūn. 16:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 5. jūn. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Quanterix Corp Prognoze

Cenas mērķis

By TipRanks

21.21% augšup

Prognoze 12 mēnešiem

Vidējais 4 USD 21.21%

Augstākais 4 USD

Zemākais 4 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Quanterix Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Quanterix Corp — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

139 / 344 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.